Procter & Gamble Co (PG)
Procter & Gamble Stock Rises on Earnings. It Shook Off a ‘Challenging' Backdrop.
The consumer packaged goods company reports better-than-expected earnings and revenue for its fiscal third quarter.
Procter & Gamble earnings beat estimates as sales grow 7%
Procter & Gamble reported quarterly earnings and revenue that topped Wall Street's expectations. The company reiterated its full-year forecast for earnings and sales.
P&G earnings preview: sales seen rising despite rich valuation
Consumer products behemoth Procter & Gamble Company (PG), is scheduled to unveil its third-quarter fiscal 2026 financial results on April 24, ahead of the market opening, with analysts anticipating year-over-year growth in both sales and earnings. For the fiscal third quarter, the Zacks Consensus Estimate forecasts Procter & Gamble will report revenues of $20.6 billion, which represents a projected 4.2% increase compared to the reported figure from the same quarter last year.
Procter & Gamble Company (The) $PG Stock Holdings Lessened by Confluence Wealth Services Inc.
Confluence Wealth Services Inc. lowered its stake in Procter and Gamble Company (The) (NYSE: PG) by 34.3% during the undefined quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 31,959 shares of the company's stock after selling 16,651 shares during the period. Confluence Wealth Services Inc.'s
Procter & Gamble cost pressures in focus for Q3 report
Procter & Gamble Co (NYSE:PG, XETRA:PRG) is set to report fiscal third-quarter earnings on April 24, with investors watching for signs that steady category demand can offset emerging cost and geopolitical pressures, according to Jefferies analysts. The consumer staples group is expected to deliver results that modestly clear Wall Street expectations, with Jefferies forecasting about 1.6% organic sales growth and earnings per share of roughly $1.56 for the quarter.
Procter & Gamble's EPS Growth Story: Sustainable or Slowing Ahead?
PG leans on pricing power, digital supply chain upgrades and cost discipline to sustain margins, though near-term EPS growth may face pressure.
Procter & Gamble: Management Said The Worst Is Over, But Q3 Earnings May Be Key
Procter & Gamble is down 14% since February, pressured by inflation, tariffs, and geopolitical tensions, but I maintain a buy rating for income investors. Q2 results showed declining margins and mixed performance, yet management reaffirmed 2026 guidance and raised the dividend, signaling confidence in future improvements. PG's forward P/E of 20.6x and robust balance sheet support continued buybacks and dividends, though near-term growth is limited and volatility may persist.
Procter & Gamble (PG) Beats Stock Market Upswing: What Investors Need to Know
The latest trading day saw Procter & Gamble (PG) settling at $146.93, representing a +2.67% change from its previous close.
Procter & Gamble (PG) Reports Next Week: Wall Street Expects Earnings Growth
P&G (PG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
PG: Earnings Next Week Can Spur A Rally
Procter & Gamble faces near-term headwinds but is set up for a potential earnings beat due to easy back-half compares and a beatable guide. Organic sales growth has slowed, especially in key segments like Fabric & Family Care, yet easing comps should support a 2%+ OSG% in the back half. PG trades near multi-year low valuations—about 21x core EPS and low-teens EV/EBITDA—while offering a 3% dividend yield and ~5% free cash flow yield.
P&G Raised Its Dividend for the 70th Year in a Row. The Stock Is Still in a Tough Spot.
Procter & Gamble plans to return $15 billion to shareholders in 2026, including spending $10 billion on the dividend and $5 billion in share repurchases.
Procter & Gamble: A Rare Opportunity To Buy At A Discount
Procter & Gamble (PG) trades near 52-week lows despite its leading CPG brands and strong balance sheet, presenting a potential opportunity. Recent results show weak growth: FY25 organic sales up 2%, core EPS up 3.6%, with Q2 2026 flat sales and EPS. PG now trades at ~20x 2026E earnings, below its 10-year average forward P/E of 23x, with a 3% dividend yield signaling modest undervaluation.
